An optical biosensor for the determination of cathepsin B as a cancer-associated enzyme using nanoporous anodic alumina modified with human serum albumin-thionine.


Journal

Mikrochimica acta
ISSN: 1436-5073
Titre abrégé: Mikrochim Acta
Pays: Austria
ID NLM: 7808782

Informations de publication

Date de publication:
13 03 2020
Historique:
received: 09 09 2019
accepted: 24 02 2020
entrez: 15 3 2020
pubmed: 15 3 2020
medline: 11 11 2020
Statut: epublish

Résumé

An interferometric reflectance spectroscopy-based biosensor for the determination of cathepsin B (Cat B) as a cancer-related enzyme has been fabricated. For this purpose, the nanoporous anodic alumina (NAA) was fabricated electrochemically. The NAA was then modified with the amino-silane coupling agent. After that, human serum albumin (HSA) was immobilized into the NAA pores by using glutaraldehyde as a cross-linking agent. Subsequently, the carboxylic group of HSA was activated with N-ethyl-N'-(3-(dimethylamino)propyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) to attach to thionine (TH) as a photoprobe to fabricate the labeled HSA (HSA-TH). HSA-TH plays a significant role in this sensor to determine cathepsin B as a model analyte for the development of the interferometric reflectance spectroscopy-based biosensor for the measurement of protease. The attached TH adsorbed the illuminated white light on NAA modified with HSA-TH. Therefore, the intensity of the reflected light to the charge-coupled device (CCD) detector decreased in the wavelength range 450-1050 nm. In the presence of Cat B, HAS-TH cleaved into short peptide fragments and washed away by flow cell system. Since TH was removed from NAA, the intensity of the reflected light increased. The peak area has a logarithmic relationship with the concentration of Cat B in the range 0.5 to 64.0 nM. The limit of detection of the biosensor sensor was 0.08 nM. The optical sensor was used for the determination of Cat B in a human serum sample. Graphical abstract Schematic presentation of biosensor for the determination of the cathepsin B which is based on nanoporous anodic alumina modified with HSA-thionine. The principle response of the optical biosensor is based on detecting changes in the intensity of the reflected light after cleaving the immobilized HSA-thionine by cathepsin B into short peptide fragments.

Identifiants

pubmed: 32170435
doi: 10.1007/s00604-020-4188-9
pii: 10.1007/s00604-020-4188-9
doi:

Substances chimiques

Phenothiazines 0
CTSB protein, human EC 3.4.22.1
Cathepsin B EC 3.4.22.1
Aluminum Oxide LMI26O6933
thionine VTT2SAT5H0
Serum Albumin, Human ZIF514RVZR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

230

Subventions

Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : (MICINN/FERDER) RTI2018-094040-B-I00
Pays : International
Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca
ID : (AGAUR) ref. 2017-SGR-1527
Pays : International

Références

J Pharm Biomed Anal. 2017 Oct 25;145:79-83
pubmed: 28651110
J Fluoresc. 2016 Nov;26(6):2165-2175
pubmed: 27553031
J Phys Chem C Nanomater Interfaces. 2013 Feb 28;117(8):4268-4277
pubmed: 23814632
ACS Appl Mater Interfaces. 2013 Aug 28;5(16):8093-8
pubmed: 23910449
Biosens Bioelectron. 2014 Jun 15;56:129-36
pubmed: 24480132
Nanomaterials (Basel). 2019 Mar 23;9(3):
pubmed: 30909598
Anal Chem. 2019 Mar 19;91(6):3971-3979
pubmed: 30726059
J Pharm Biomed Anal. 2014 Jul;95:47-53
pubmed: 24631956
Science. 1997 Oct 31;278(5339):840-3
pubmed: 9346478
Korean J Food Sci Anim Resour. 2014;34(2):151-7
pubmed: 26760932
Eur J Med Chem. 2019 Oct 1;179:828-836
pubmed: 31295715
ACS Nano. 2010 Apr 27;4(4):2070-6
pubmed: 20356100
Biosens Bioelectron. 2019 Jul 15;137:279-286
pubmed: 31125817
ACS Appl Mater Interfaces. 2019 Jan 23;11(3):3360-3371
pubmed: 30590008
ACS Appl Mater Interfaces. 2018 Mar 28;10(12):10571-10579
pubmed: 29509406
Int J Oncol. 2013 Feb;42(2):373-83
pubmed: 23291656
Sci Rep. 2017 Oct 17;7(1):13341
pubmed: 29042657
Biotechnol Appl Biochem. 1988 Jun;10(3):294-300
pubmed: 3395470
Nanomedicine. 2015 Oct;11(7):1695-704
pubmed: 25959927
Nanoscale Res Lett. 2012 Jul 03;7(1):370
pubmed: 22759928
Theranostics. 2012;2(2):179-89
pubmed: 22375156
Langmuir. 2016 Jul 26;32(29):7372-82
pubmed: 27352148
Anal Chem. 2004 May 1;76(9):2664-8
pubmed: 15117213
Biomaterials. 2007 Jun;28(16):2638-45
pubmed: 17335895

Auteurs

Mahmoud Amouzadeh Tabrizi (M)

Departamento de Ingeniería Electrónica, Eléctrica y Automática, Universitat Rovira i Virgili, Avda. Països Catalans 26, 43007, Tarragona, Spain.

Josep Ferré-Borrull (J)

Departamento de Ingeniería Electrónica, Eléctrica y Automática, Universitat Rovira i Virgili, Avda. Països Catalans 26, 43007, Tarragona, Spain.

Lluis F Marsal (LF)

Departamento de Ingeniería Electrónica, Eléctrica y Automática, Universitat Rovira i Virgili, Avda. Països Catalans 26, 43007, Tarragona, Spain. lluis.marsal@urv.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH